Massachusetts Institute of Technology Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$31.8M |
| 2 |
DADA
Dada Nexus
DADA
|
+$3.21M |
| 3 |
ADVM
Adverum Biotechnologies
ADVM
|
+$1.66M |
| 4 |
Ocular Therapeutix
OCUL
|
+$748K |
| 5 |
Ribbon Communications
RBBN
|
+$737K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Salesforce
CRM
|
+$8.37M |
| 2 |
CRISPR Therapeutics
CRSP
|
+$1.85M |
| 3 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
+$870K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 64.73% |
| 2 | Technology | 28.54% |
| 3 | Consumer Discretionary | 3.54% |
| 4 | Healthcare | 3.19% |
Similar funds
Massachusetts Institute of Technology's Q4 2020 Portfolio in Review
As of Q4 2020, Massachusetts Institute of Technology held 12 positions worth $89.2M, up 98% from $45.1M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Massachusetts Institute of Technology deployed $27.6M of net new capital in Q4 2020, opening 6 new positions and adding to 1 existing holding. Its largest new stake was Zoom: 71,339 shares worth $24.1M.
By sector, the portfolio is most concentrated in Industrials at 65% of assets, down from 75% a quarter earlier, followed by Technology and Consumer Discretionary.
On the sell side, the most notable exit was Salesforce, an estimated $8.37M sold.
- Massachusetts Institute of Technology's largest Q4 2020 buy was Zoom: 71,339 shares worth $24.1M.
- Massachusetts Institute of Technology added most to Apple in Q4 2020, an estimated $83.2K increase.
- Massachusetts Institute of Technology fully exited Salesforce in Q4 2020, selling an estimated $8.37M.
- Massachusetts Institute of Technology's ten largest holdings make up 100% of its $89.2M portfolio in Q4 2020.
- Massachusetts Institute of Technology opened 6 new positions and closed 3 in Q4 2020.
- Massachusetts Institute of Technology's portfolio value rose 98% quarter-over-quarter to $89.2M.
Based on Massachusetts Institute of Technology's 13F filing for Q4 2020, filed 5 Feb 2021.